Highlight news
Obesity is a complex, chronic condition and a significant contributor to cardiovascular risk. For GPs, the intersection of obesity and CVD is increasingly relevant in day-to-day care, from risk assessment and diagnosis through to GLP-1 receptor agonist treatment decisions and long-term follow-up.
The Heart Foundation’s Obesity and CVD clinical consensus statement provides practical, evidence-based guidance for healthcare professionals caring for adults living with overweight or obesity who have established CVD or are at high risk.
Developed with a multidisciplinary taskforce of clinical experts and people with lived experience, the statement covers diagnosis and assessment, the implications of obesity for cardiovascular diagnostics, behaviour modifications, pharmacological and surgical interventions, lifelong care and follow-up, weight stigma, and equity
considerations for high-priority populations, including people living in rural and remote areas.
The statement is designed to support healthcare professionals with contemporary guidance in an evolving area of medicine, including the role of obesity management medications with demonstrated cardiovascular benefits and practical approaches to patient-centred care.
For GPs working in rural and remote communities, the statement offers a timely resource to support consistent, evidence-informed care and strengthen conversations with patients about obesity, cardiovascular risk and long-term heart health.
All news
Obesity is a complex, chronic condition and a significant contributor to cardiovascular risk. For GPs, the intersection of obesity and CVD is increasingly relevant in day-to-day care, from risk assessment and diagnosis through to GLP-1 receptor agonist treatment decisions and long-term follow-up.
The Heart Foundation’s Obesity and CVD clinical consensus statement provides practical, evidence-based guidance for healthcare professionals caring for adults living with overweight or obesity who have established CVD or are at high risk.
Developed with a multidisciplinary taskforce of clinical experts and people with lived experience, the statement covers diagnosis and assessment, the implications of obesity for cardiovascular diagnostics, behaviour modifications, pharmacological and surgical interventions, lifelong care and follow-up, weight stigma, and equity
considerations for high-priority populations, including people living in rural and remote areas.
The statement is designed to support healthcare professionals with contemporary guidance in an evolving area of medicine, including the role of obesity management medications with demonstrated cardiovascular benefits and practical approaches to patient-centred care.
For GPs working in rural and remote communities, the statement offers a timely resource to support consistent, evidence-informed care and strengthen conversations with patients about obesity, cardiovascular risk and long-term heart health.